Needle-Free IV Connectors Market Is Projected To Reach US$ 2.98 Bn By 2033

The rising adoption of home healthcare and the increasing number of cases related to contagious diseases are driving the growth of the needle-free IV connectors market. Several companies in the needle-free IV connectors market are focusing on developing advanced needleless connectors.

Needless devices that link administration sets, syringes, and IV catheters are known as needle-free IV connectors. To safeguard the hubs in vascular access systems, these connectors are commonly utilized in hospitals for the intravenous delivery of various fluids and liquids.

Download a Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8383?PS

The global needle-free IV connectors market is valued at US$ 1.26 billion in 2023 and is projected to reach US$ 2.98 billion by the end of 2033. Global sales of needle-free IV connectors are expected to increase at a high-value CAGR of 9% during the next 10 years

The Fact.MR analysts have made use of varied industry-wide prominent tools of market intelligence to gather, collate, and analyze market data, figures, and facts to arrive at revenue estimations and projections in the Global Needle-free IV Connectors Market. 

Key Companies Profiled

• B. Braun Melsungen AG
• Baxter International, Inc.
• Becton, Dickinson and Company
• CareFusion Corporation
• ICU Medical, Inc.
• Nexus Medical LLC
• RyMed Technologies, LLC
• Vygon SA

Some of the factors boosting needle-free IV connector sales in the United States include improved healthcare infrastructure, an ageing society, and a greater understanding of the advantages of needleless connectors among healthcare professionals.

Get Customization on this Report for Specific Research Solutions:  https://www.factmr.com/connectus/sample?flag=RC&rep_id=8383?PS

Rising prevalence of cardiovascular disorders, advancements in drug delivery systems, and growing adoption of minimally-invasive procedures are boosting the demand for needleless devices.

• In August 2021, Boehringer Ingelheim GmbH released a press statement describing heart failure as a chronic, incapacitating cardio-renal-metabolic condition that affects more than 60 million individuals globally.
• More than 700 million individuals around the world are living with untreated hypertension, according to the World Health Organization (WHO) 2021 report. Additionally, hypertension sharply raises the risk of renal, heart, and brain disorders, according to the same source.

To understand of the competitive landscape in the Global Needle-free IV Connectors Market better, the report covers the profile of the following top players: 

Industry challenges together with the latest developments in the technological developments of the Global Needle-free IV Connectors Market have been elaborated on in the market intelligence report.

It also provides a detailed picture of the trends of the changing industry structure and the challenges that are faced by various industry participants. The report elaborates on the major challenges that the participants of the said market could possibly across the globe. 

What Do You Get in a Fact.MR Study?

• Factors affecting the overall development of the Needle-free IV Connectors Market
• Factor that might restrain the growth of the global Needle-free IV Connectors market in the coming years of the forecast period 
• What is present competitive scenario of the global Needle-free IV Connectors Market and its intricate details concerning potential business prospects of leading market players
• Pricing strategies of several different market players in the global Market